PubMed:21789713
Annnotations
PubmedHPO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 233-248 | HP_0012125 | denotes | prostate cancer |
T2 | 242-248 | HP_0002664 | denotes | cancer |
T3 | 1595-1623 | HP_0008711 | denotes | benign prostatic hyperplasia |
T4 | 1657-1666 | HP_0002664 | denotes | neoplasia |
Allie
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
SS1_21789713_1_0 | 199-217 | expanded | denotes | castrate-resistant |
SS2_21789713_1_0 | 219-221 | abbr | denotes | CR |
SS1_21789713_1_1 | 315-332 | expanded | denotes | androgen receptor |
SS2_21789713_1_1 | 334-336 | abbr | denotes | AR |
SS1_21789713_3_0 | 889-910 | expanded | denotes | nuclear factor-kappaB |
SS2_21789713_3_0 | 912-917 | abbr | denotes | NF-κB |
SS1_21789713_7_0 | 1595-1623 | expanded | denotes | benign prostatic hyperplasia |
SS2_21789713_7_0 | 1625-1628 | abbr | denotes | BPH |
AE1_21789713_1_0 | SS1_21789713_1_0 | SS2_21789713_1_0 | abbreviatedTo | castrate-resistant,CR |
AE1_21789713_1_1 | SS1_21789713_1_1 | SS2_21789713_1_1 | abbreviatedTo | androgen receptor,AR |
AE1_21789713_3_0 | SS1_21789713_3_0 | SS2_21789713_3_0 | abbreviatedTo | nuclear factor-kappaB,NF-κB |
AE1_21789713_7_0 | SS1_21789713_7_0 | SS2_21789713_7_0 | abbreviatedTo | benign prostatic hyperplasia,BPH |
CoMAGC
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 1692-1696 | Gene | denotes | RLN2 |
E2 | 1714-1725 | Positive_regulation | denotes | upregulated |
T2 | 1631-1666 | prostate cancer | denotes | prostatic intraepithelial neoplasia |
T3 | 1595-1623 | prostate cancer | denotes | benign prostatic hyperplasia |
T4 | 1625-1628 | prostate cancer | denotes | BPH |
T5 | 1736-1739 | prostate cancer | denotes | BPH |
R1 | T1 | E2 | themeOf | RLN2,upregulated |
R3 | T1 | T2 | CGE-increased | RLN2,prostatic intraepithelial neoplasia |
R4 | T1 | T2 | CCS-normalTOcancer | RLN2,prostatic intraepithelial neoplasia |
R5 | T1 | T2 | PT-observation | RLN2,prostatic intraepithelial neoplasia |
R3 | T1 | T2 | IGE-unidentifiable | RLN2,prostatic intraepithelial neoplasia |